Genomtec Investor Relations Material
Latest events
Investor Update
Genomtec
Q1 2025
29 May, 2025
Q4 2024
29 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Genomtec S.A
Access all reports
Genomtec S.A. is a biotechnology company specializing in molecular diagnostics. The company develops and commercializes portable and laboratory-based diagnostic solutions using isothermal nucleic acid amplification technology. Its products are designed for rapid and precise detection of infectious diseases, genetic disorders, and other medical conditions. The company is headquartered in Wrocław, Poland, and its shares are listed on the WSE.
Key slides for Genomtec S.A
Investor Update
Genomtec S.A
Investor Update
Genomtec S.A
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
GMT
Country
🇵🇱 Poland